Trial intelligence / Profile preview

ACYW135 meningococcal polysaccharide vaccine post-marketing safety and immunogenicity study

CTR20150843Phase 4Completed

Sponsor
Yuxi Watson Biotechnology
Start
Apr 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of A, C, Y, W135 meningococcal polysaccharide vaccine in meningococcal meningitis, sponsored by Yuxi Watson Biotechnology. Started Apr 2016; status: completed.

02

Drugs

A, C, Y, W135 meningococcal polysaccharide vaccine
03

Conditions

meningococcal meningitis

Beyond the preview

Go deeper on CTR20150843.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150843.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call